Introduction
Synthesized predominantly by the liver, the serum peptide hepcidin inhibits duodenal iron absorption and macrophage iron efflux. 1 Hepcidin expression is regulated by several factors including iron, anemia, hypoxia and inflammation. Using the hypotransferrinemic mouse, a model of transferrin deficiency characterized by anemia, hepcidin deficiency and iron overload, we recently demonstrated that the serum ironbinding protein transferrin is a key determinant of hepcidin expression. 2 Given that iron-dependent hepcidin expression is mediated in part by genes mutated in hereditary hemochromatosis, a disease of hepcidin deficiency and iron overload, we hypothesized that transferrin-dependent hepcidin expression in hpx mice requires function of hemochromatosis genes. To test this hypothesis, we generated mice deficient in both transferrin (Tf hpx/hpx ) and hemojuvelin (Hjv -/-), a gene mutated in juvenile hemochromatosis, 3, 4 and characterized the response of these mice to transferrin treatment and red blood cell (RBC) transfusions.
Design and Methods

Tf
hpx/hpx and Hjv -/-mice were maintained respectively on the BALB/cJ and C57BL/6J backgrounds, as previously described. 2 Hjv -/-pups were injected intraperitoneally with 3 mg purified human transferrin (Roche) once a week until weaning at Day 21 to ensure their survival. All experiments were performed on 8-week old mice.
For transferrin treatment of adult mice, mice were injected intraperitoneally with 10 mg transferrin (Roche) every other day. For RBC transfusions, EDTA-anticoagulated blood was collected, centrifuged and washed with PBS four times to remove plasma, then injected into recipients intraperitoneally. Parameters of erythropoiesis and iron metabolism were measured as previously described. 2 All statistical analyses were performed using Microsoft Excel. Student's two-tailed t-test P values (unpaired; unequal variance) at <0.05 were considered significantly different. As far as PBS treatment is concerned, both transferrin treatment and RBC transfusions increased hemoglobin levels and decreased spleen masses in both genotypes of mice (Figure 2A and B) , while only transferrin treatment increased serum iron levels and total iron binding capacities in both genotypes ( Figure 2C and D Figure 2H ). Hepcidin regulation in hpx mice can be described in terms of the stores-and erythroid-regulators. Proposed decades ago to explain the regulation of iron homeostasis by various phenomena, 6 and described here in the context of the central role of hepcidin in iron homeostasis, the stores-regulator stimulates hepcidin expression in conditions of iron overload, while the erythroid-regulator inhibits hepcidin expression in conditions of aberrant erythropoiesis. Our studies implicate transferrin and hemojuvelin as essential components of the stores-regulator but not the erythroid-regulator. A role for transferrin and hemojuvelin in stores-regulator activity is suggested by the increase in hepcidin levels in myeloablated hpx mice treated with transferrin 2 While our studies suggest that transferrin and hemojuvelin are not essential components of the erythroid-regulator, the lack of an increase in hepcidin levels in RBCtransfused Tf hpx/hpx Hjv -/-mice, and the modest increase in hepcidin levels in Tf-transfused Tf hpx/hpx Hjv -/-mice, suggests that the erythroid-regulator active in untreated hpx mice may inhibit hepcidin expression by modulating activity along the hemojuvelin-hepcidin signaling pathway. Possible targets of erythroid-regulator activity include BMP receptors or co-receptors such as hemojuvelin, endogenous stimulators of hepcidin expression like BMP6 or downstream mediators of BMP signaling. In vivo modulators of hepcidin expression have already been identified; for example, the hepatic membrane protein transmembrane protease serine 6 (Tmprss6) decreases hepcidin expression by cleaving hemojuvelin from the cell membrane. 7 Given that our preliminary data suggest that Tf hpx/hpx Tmprss6 -/-mice are not viable (data not shown), exploration of the role of Tmprss6 in hepcidin regulation in hpx mice will require the construction of conditional Tmprss6 alleles or the use of other methods. While a role for BMP antagonists Gdf15 and Twsg1 in hepcidin regulation has yet to be demonstrated in vivo, both antagonize hepcidin expression in vitro and are over-expressed in Tf hpx/hpx mice. 2, 8 Examination of the role of these factors in hepcidin regulation in Tf hpx/hpx mice will require an approach similar to that taken with hemojuvelin in this report.
Results and Discussion
We propose the following model for transferrin-centric hepcidin regulation (Figure 3) . Erythropoiesis in untreated hpx mice leads to activation of the erythroid-regulator Hemojuvelin and transferrin-dependent and independent hepcidin expression haematologica | 2012; 97 (2) 191 which inhibits stores-regulator mediated hepcidin expression. With RBC transfusions, the inhibitory effects of the erythroid-regulator are lifted and hepcidin expression, wholly hemojuvelin-dependent, is stimulated by factors other than transferrin such as Bmp6. A similar process occurs in hpx mice treated with transferrin, except that in these mice hepcidin expression is stimulated additionally by administered transferrin. Overall, transferrin and hemojuvelin play essential yet distinct functions: transferrin directly stimulates liver hepcidin expression and delivers iron for erythropoiesis so that the inhibitory effects of anemia and hypoxia on hepcidin expression are minimized, while hemojuvelin mediates the stimulation of hepcidin expression by transferrin and other factors.
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haematologica | 2012; 97(2) Figure 3 . Model of transferrindependent regulation of hepcidin expression in hypotransferrinemic mice. Hepcidin expression is regulated by the activity of the storesand erythroid-regulators. Storesregulator activity, mediated by transferrin (Tf) and BMP6, stimulates hepcidin expression in a hemojuvelin-dependent manner. Erythroid-regulator activity, possibly mediated by Tmprss6, Gdf15 and Twsg1, inhibits hemojuvelin-dependent hepcidin expression. Erythroidregulator activity in hpx mice can be diminished by RBC transfusions or transferrin (TF) administration.
